2.0
Feb 14, 2016
Former employee, more than 3 years
Dallas, TX
Recommend
CEO approval
Business Outlook
Pros
Good access, experience overcoming adversity
Cons
No development opportunity, no new products, no reputable clinical or new competitive data on current products, incentive comp plan is inadequate, unsustainable, and unclear to both reps and those running it, apathetic national account direction, unqualified and unethical senior leadership.